TY - JOUR
AU - Alexandra Savinkina
AU - Rajapaksha W. M. A. Madushani
AU - Golnaz Eftekhari Yazdi
AU - Jianing Wang
AU - Joshua A. Barocas
AU - Jake R. Morgan
AU - Sabrina A. Assoumou
AU - Alexander Y. Walley
AU - Benjamin P. Linas
AU - Sean M. Murphy
A1 - 
AD - Section of Infectious Diseases, Boston Medical Center (BMC), Boston, MA, US alexandra.savinkina@bmc.org; Boston University, School of Public Health, Boston, MA, US ; Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, US ; Department of Population Health Sciences, Weill Cornell Medical College, New York, NY, US ; Savinkina, Alexandra,Medical Campus, 801 Massachusetts Avenue, 2nd Floor,Boston,US,02131,Boston University,alexandra.savinkina@bmc.org
BT - Addiction
C5 - Opioids & Substance Use ; Financing & Sustainability
CP - 9
DB - APA PsycInfo®
DO - 10.1111/add.15879
IS - 9
JF - Addiction
LA - English
PY - 2022
SN - 0965-2140, 0965-2140
SP - 2450
EP - 2461+
ST - Population‐level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: An effectiveness and cost‐effectiveness analysis
T1 - Population‐level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: An effectiveness and cost‐effectiveness analysis
T2 - Addiction
TI - Population‐level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: An effectiveness and cost‐effectiveness analysis
U1 - Opioids & Substance Use ; Financing & Sustainability
U3 - 10.1111/add.15879
VL - 117
VO - 0965-2140, 0965-2140
Y1 - 2022
ER -